Literature DB >> 19548084

Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt.

Subhojit Dey1, Amr S Soliman, Ahmad Hablas, Ibrahim A Seifeldin, Kadry Ismail, Mohamed Ramadan, Hesham El-Hamzawy, Mark L Wilson, Mousumi Banerjee, Paolo Boffetta, Joe Harford, Sofia D Merajver.   

Abstract

Breast cancer incidence is higher in developed countries with higher rates of estrogen receptor positive (ER+) tumors. ER+ tumors are caused by estrogenic exposures although known exposures explain approximately 50% of breast cancer risk. Unknown risk factors causing high breast cancer incidence exist that are estrogenic and development-related. Xenoestrogens are such risk factors but are difficult to study since developed countries lack unexposed populations. Developing countries have urban-rural populations with differential exposure to xenoestrogens. This study assessed urban-rural breast cancer incidence classified by hormone receptor status using data from Gharbiah population-based cancer registry in Egypt from 2001 to 2006. Urban ER+ incidence rate (per 100,000 women) was 2-4 times (IRR = 3.36, 95% CI = 4.84, 2.34) higher than rural incidence rate. ER-incidence rate was 2-3 times (IRR = 1.86, 95% CI = 2.38, 1.45) higher in urban areas than in rural areas. Our findings indicate that urban women may probably have a higher exposure to xenoestrogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548084      PMCID: PMC2808467          DOI: 10.1007/s10549-009-0427-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  43 in total

1.  Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability.

Authors:  B Rockhill; C R Weinberg; B Newman
Journal:  Am J Epidemiol       Date:  1998-05-01       Impact factor: 4.897

Review 2.  Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.

Authors:  Daniel R Ciocca; Francisco E Gago; Mariel A Fanelli; Stuart K Calderwood
Journal:  J Steroid Biochem Mol Biol       Date:  2006-10-17       Impact factor: 4.292

3.  Oestrogen receptor alpha in female fetal, infant, and child mammary tissue.

Authors:  J W Keeling; E Ozer; G King; F Walker
Journal:  J Pathol       Date:  2000-08       Impact factor: 7.996

4.  DDT supports the growth of an estrogen-responsive tumor.

Authors:  A K Robison; D A Sirbasku; G M Stancel
Journal:  Toxicol Lett       Date:  1985-09       Impact factor: 4.372

Review 5.  Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research.

Authors:  Judy S LaKind; A Amina Wilkins; Cheston M Berlin
Journal:  Toxicol Appl Pharmacol       Date:  2004-07-15       Impact factor: 4.219

6.  Human hair as a potential biomonitor for assessing persistent organic pollutants.

Authors:  Hong Zhang; Zhifang Chai; Huibin Sun
Journal:  Environ Int       Date:  2007-03-26       Impact factor: 9.621

7.  Spatial and temporal trends of chiral organochlorine signatures in Great Lakes air using passive air samplers.

Authors:  T Gouin; L Jantunen; T Harner; P Blanchard; T Bidleman
Journal:  Environ Sci Technol       Date:  2007-06-01       Impact factor: 9.028

Review 8.  Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?

Authors:  Julia Green Brody; Ruthann A Rudel; Karin B Michels; Kirsten B Moysich; Leslie Bernstein; Kathleen R Attfield; Sharon Gray
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

Review 9.  Environmental pollutants and breast cancer: epidemiologic studies.

Authors:  Julia Green Brody; Kirsten B Moysich; Olivier Humblet; Kathleen R Attfield; Gregory P Beehler; Ruthann A Rudel
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

Review 10.  The changing global patterns of female breast cancer incidence and mortality.

Authors:  Freddie Bray; Peter McCarron; D Maxwell Parkin
Journal:  Breast Cancer Res       Date:  2004-08-26       Impact factor: 6.466

View more
  25 in total

1.  Public and professional educational needs for downstaging breast cancer in Egypt.

Authors:  Nazneen Uddin; Elham Fateem; Ahmed Hablas; Ibrahim A Seifeldin; Elissa Brown; Sofia D Merajver; Amr S Soliman
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

Review 2.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal.

Authors:  Subhojit Dey
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Head and neck cancer in a developing country: a population-based perspective across 8 years.

Authors:  Esra Attar; Subhojit Dey; Ahmad Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Laura S Rozek; Amr S Soliman
Journal:  Oral Oncol       Date:  2010-07-08       Impact factor: 5.337

4.  Geographic distribution of hematopoietic cancers in the Nile delta of Egypt.

Authors:  C M Herzog; S Dey; A Hablas; H M Khaled; I A Seifeldin; M Ramadan; H El-Hamzawy; M L Wilson; A S Soliman
Journal:  Ann Oncol       Date:  2012-05-02       Impact factor: 32.976

5.  Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients.

Authors:  Samuel F Gilbert; Amr S Soliman; Maria Iniesta; Mohab Eissa; Ahmed Hablas; Ibrahim A Seifeldin; Ashley Strahley; Mousumi Banerjee; Sofia D Merajver
Journal:  Breast Cancer Res Treat       Date:  2011-04-20       Impact factor: 4.872

6.  Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.

Authors:  Jennifer A Schlichting; Amr S Soliman; Catherine Schairer; Mousumi Banerjee; Laura S Rozek; David Schottenfeld; Joe B Harford; Sofia D Merajver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

7.  Urban-rural differences of gynaecological malignancies in Egypt (1999-2002).

Authors:  S Dey; A Hablas; I A Seifeldin; K Ismail; M Ramadan; H El-Hamzawy; M L Wilson; M Banerjee; P Boffetta; J Harford; S D Merajver; A S Soliman
Journal:  BJOG       Date:  2009-12-16       Impact factor: 6.531

8.  Incidence analyses of bladder cancer in the Nile delta region of Egypt.

Authors:  Stacey A Fedewa; Amr S Soliman; Kadry Ismail; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Hoda G Omar; Jerome Nriagu; Mark L Wilson
Journal:  Cancer Epidemiol       Date:  2009-09-16       Impact factor: 2.984

9.  Measuring the effect of improvement in methodological techniques on data collection in the Gharbiah population-based cancer registry in Egypt: Implications for other Low- and Middle-Income Countries.

Authors:  Brittney L Smith; Mohamed Ramadan; Brittany Corley; Ahmed Hablas; Ibrahim A Seifeldein; Amr S Soliman
Journal:  Cancer Epidemiol       Date:  2015-11-18       Impact factor: 2.984

10.  Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registry.

Authors:  Darlene Veruttipong; Amr S Soliman; Samuel F Gilbert; Taylor S Blachley; Ahmed Hablas; Mohamed Ramadan; Laura S Rozek; Ibrahim A Seifeldin
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.